GO Term |
---|
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO Term |
---|
Golgi apparatus |
plasma membrane |
microvillus |
secretory granule membrane |
cell projection |
extracellular exosome |
basolateral plasma membrane |
apical plasma membrane |
lamellipodium membrane |
cytosol |
GO Term |
---|
transmembrane signaling receptor activity |
cytokine receptor activity |
collagen binding |
hyaluronic acid binding |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
199 |
|
|||
200 |
|
|||
271 |
|
|||
282 |
|
|
||
318 |
|
|||
325 |
|
|||
330 |
|
|||
332 |
|
|||
350 | N-linked (GlcNAc...) asparagine |
|
||
398 |
|
Pathway Name | Organism |
---|---|
Cell surface interactions at the vascular wall | Homo sapiens |
Degradation of the extracellular matrix | Homo sapiens |
Hyaluronan uptake and degradation | Homo sapiens |
Integrin cell surface interactions | Homo sapiens |
Interferon gamma signaling | Homo sapiens |
Neutrophil degranulation | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:0110302 | obsolete autosomal dominant limb-girdle muscular dystrophy type 1C | |
DOID:0110303 | autosomal dominant limb-girdle muscular dystrophy type 1H | |
DOID:0110304 | autosomal dominant limb-girdle muscular dystrophy type 2 | |
DOID:0110305 | autosomal dominant limb-girdle muscular dystrophy type 1 | |
DOID:0110306 | autosomal dominant limb-girdle muscular dystrophy type 3 | |
DOID:0110334 | osteogenesis imperfecta type 1 | |
DOID:0110335 | osteogenesis imperfecta with opalescent teeth, blue sclerae and wormian bones but without fractures | |
DOID:0110336 | osteogenesis imperfecta type 8 | |
DOID:0110337 | osteogenesis imperfecta type 7 | |
DOID:0110338 | osteogenesis imperfecta type 17 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024